Document Detail


Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
MedLine Citation:
PMID:  9357969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Stem cell factor (SCF) is a glycoprotein growth factor produced by marrow stromal cells that acts after binding to its specific surface receptor, which is the protein encoded by the protooncogene c-kit. SCF synergizes with specific lineage factors in promoting the proliferation of primitive hematopoietic progenitors, and has been administered to expand the pool of these progenitors in cancer patients treated with high-dose chemotherapy. SCF and its c-kit receptor are expressed by some tumor cells, including myeloid leukemia, breast carcinoma, small cell lung carcinoma, melanoma, gynecological tumors, and testicular germ cell tumors. Previous studies of SCF in neuroblastoma have produced conflicting conclusions. To explore the role of SCF in neuroblastoma, we studied five neuroblastoma lines (IMR-5, SK-N-SH, SK-N-BE, AF8, and SJ-N-KP) and the neuroepithelioma line CHP-100. All lines expressed mRNA for c-kit and c-kit protein at low intensity as measured by flow cytometry, and secreted SCF in medium culture as shown by ELISA. Exogenous SCF did not modify 3H thymidine uptake in the neuroblastoma and neuroepithelioma cell lines. After 6 days' culture in the presence of anti-c-kit, the number of viable neuroblastoma cells was significantly lower than the control, and terminal deoxynucleotidyl transferase assay showed a substantial increase of apoptotic cells: The percentage of positive cells was 1-3% in the control lines, whereas in the presence of anti c-kit it varied from 29% of SK-N-BE to 92% of CHP-100. After 9 days' culture in the presence of anti-c-kit, no viable cells were detectable. These data indicate that SCF is produced by some neuroblastoma cell lines via an autocrine loop to protect them from apoptosis.
Authors:
F Timeus; N Crescenzio; P Valle; P Pistamiglio; M Piglione; E Garelli; E Ricotti; P Rocchi; P Strippoli; L Cordero di Montezemolo; E Madon; U Ramenghi; G Basso
Related Documents :
10030849 - Respiratory carcinoma cell lines. muc genes and glycoconjugates.
21273179 - Cell cycle protein cyclin y is associated with human non-small-cell lung cancer prolife...
3567899 - Cell culture of human colon adenomas and carcinomas.
18320189 - Antibody variable-region sequencing as a method for hybridoma cell-line authentication.
19263179 - Establishment and characterization of a fibroblast cell line from the mongolian horse.
1713449 - Production of muc1 and muc2 mucins by human tumor cell lines.
17535349 - Interaction between chromaffin and sustentacular cells in adrenal medulla of viscacha (...
25204229 - Ww domain of bag3 is required for the induction of autophagy in glioma cells.
19578399 - Interactions between cells with distinct mutations in c-myc and pten in prostate cancer.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Experimental hematology     Volume:  25     ISSN:  0301-472X     ISO Abbreviation:  Exp. Hematol.     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1997-11-20     Completed Date:  1997-11-20     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0402313     Medline TA:  Exp Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1253-60     Citation Subset:  IM    
Affiliation:
Dipartimento di Scienze Pediatriche, University of Torino, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal
Apoptosis / drug effects*
Gene Expression Regulation, Neoplastic / drug effects
Humans
Mitogens / pharmacology*
Neuroblastoma / pathology*
Neuroectodermal Tumors, Primitive, Peripheral / pathology*
Proto-Oncogene Proteins c-kit / genetics,  physiology*
RNA, Messenger / genetics
RNA, Neoplasm / genetics
Stem Cell Factor / biosynthesis,  pharmacology*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Mitogens; 0/RNA, Messenger; 0/RNA, Neoplasm; 0/Stem Cell Factor; EC 2.7.10.1/Proto-Oncogene Proteins c-kit

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T ...
Next Document:  Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of a...